Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Clinical Nephrology|January 20, 2016
Glomerular size reduction associated with severe cardiorenal syndromeJanice Desir, Joel Neugarten, Michal Melamed, et al.
International Urology and Nephrology|January 17, 2017
Improving the diagnostic workup of hyponatremia in the setting of kidney disease: a continuing medical education (CME) initiativeLadan Golestaneh, Joel Neugarten, William Southern, et al.
Kidney International|November 13, 2002
Estradiol reverses TGF-beta1-induced mesangial cell apoptosis by a casein kinase 2-dependent mechanismOlivia Negulescu, Istvan Bognar, Jun Lei, et al.
Kidney International|December 1, 2004
Estradiol reverses renal injury in Alb/TGF-beta1 transgenic miceJoel Blush, Jun Lei, Wenjun Ju, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 5, 2025
Kidney Health and Gender-Affirming Hormone Therapy for Transgender and Gender Diverse IndividualsPatel Reema, Shira Grock, Hill L Wolfe, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 18, 2026
The Effect of Gender-Affirming Hormone Treatment on Kidney Function Trajectories in Transgender and Gender Diverse VeteransNicholas Jackson, Neda Buljubasic, Kamyar Kalantar-Zadeh, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 24, 2024
Sex, Acute Kidney Injury, and Age: A Prospective Cohort StudyLadan Golestaneh, Abby Basalely, Andreas Linkermann, et al.
Kidney International|October 8, 2010
Raloxifene, a selective estrogen receptor modulator, is renoprotective: a post-hoc analysisMichal L Melamed, Terri Blackwell, Joel Neugarten, et al.
Journal of the American Society of Nephrology : JASN|July 17, 2020
AKI in Hospitalized Patients with and without COVID-19: A Comparison StudyMolly Fisher, Joel Neugarten, Eran Bellin, et al.
Pageof 4